Categories: world

The FDA approves pioneering cancer drugs

November 28, 2018 Health 1 Views The FDA has approved Vitrakvi for adult and pediatric patients whose cancer has a…

The FDA has approved Vitrakvi for adult and pediatric patients whose cancer has a specific biomarker. (Photo: Bayer)

(CNN) &#821

1; The FDA has approved what may be a breakthrough drug in the treatment of certain cancers.

It is called Vitrakvi.

The drug is designed to combat a specific genetic mutation in some forms of cancer.

And it comes in an easy-to-take capsule or in liquid form.

Doctors say that some patients, including children, have seen remarkable twists.

But they warn that it does not work for all cancers, and it’s expensive!

“We now have the opportunity to ensure that proper patients receive proper treatment at the right time. This type of drug development program, which registered patients with different tumors but a common gene mutation, would not have been possible a decade ago because we knew a lot less about such cancermutations. “FDA Commissioner Dr. Scott Gottlieb said in a statement

The wholesale cost of children’s syrup is $ 11,000 for a month.

And the oral capsules for adult wholesalers for $ 32,000 a month.

However, with insurance, most patients would pay $ 20.00 or less for a 30-day delivery of the drug.


Source link

Share
Published by
Faela